- Home
- GECC vs TELO Comparison
GECC vs TELO Comparison
Compare GECC & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GECC
- TELO
- Stock Information
- Founded
- GECC 2016
- TELO 2021
- Country
- GECC United States
- TELO United States
- Employees
- GECC N/A
- TELO N/A
- Industry
- GECC Finance: Consumer Services
- TELO
- Sector
- GECC Finance
- TELO
- Exchange
- GECC Nasdaq
- TELO NYSE
- Market Cap
- GECC 106.1M
- TELO 124.1M
- IPO Year
- GECC N/A
- TELO 2024
- Fundamental
- Price
- GECC $10.13
- TELO $4.47
- Analyst Decision
- GECC
- TELO
- Analyst Count
- GECC 0
- TELO 0
- Target Price
- GECC N/A
- TELO N/A
- AVG Volume (30 Days)
- GECC 13.2K
- TELO 75.3K
- Earning Date
- GECC 10-31-2024
- TELO 11-12-2024
- Dividend Yield
- GECC 13.79%
- TELO N/A
- EPS Growth
- GECC N/A
- TELO N/A
- EPS
- GECC 0.65
- TELO N/A
- Revenue
- GECC $39,468,000.00
- TELO N/A
- Revenue This Year
- GECC $16.95
- TELO N/A
- Revenue Next Year
- GECC $7.48
- TELO N/A
- P/E Ratio
- GECC $15.57
- TELO N/A
- Revenue Growth
- GECC 16.86
- TELO N/A
- 52 Week Low
- GECC $9.55
- TELO $3.11
- 52 Week High
- GECC $11.82
- TELO $20.72
- Technical
- Relative Strength Index (RSI)
- GECC 52.77
- TELO 50.96
- Support Level
- GECC $9.99
- TELO $3.20
- Resistance Level
- GECC $10.37
- TELO $4.73
- Average True Range (ATR)
- GECC 0.15
- TELO 0.45
- MACD
- GECC 0.02
- TELO 0.06
- Stochastic Oscillator
- GECC 65.22
- TELO 72.69
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. The company seeks to generate current income and capital appreciation through debt and equity investments, including investments in specialty finance businesses. It invests in senior secured and senior unsecured debt instruments, as well as in junior loans and mezzanine debt of middle-market companies and small businesses. The company generates revenue from interest on the debt investments that it holds.
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.